Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.17 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Merck & Co. Stock: Is MRK Outperforming the Healthcare Sector?
Merck has outperformed the healthcare sector over the past three months. Moreover, Wall Street analysts are moderately optimistic about its prospects. 
Via Barchart.com
Topics ETFs
News headline image
Did Pfizer Just Say "Checkmate" to Novo Nordisk? ↗
The weight loss drug market may approach almost $100 billion by the end of the decade. 
Via The Motley Fool
News headline image
The Data Vacuum: How Delayed Economic Reports Are Clouding Market Stability and Investor Confidence
The financial markets are currently navigating a turbulent sea of uncertainty, grappling with the profound implications of significantly delayed economic reports. As of November 25, 2025, the... 
Via MarketMinute
Topics Bonds Credit Cards Economy
News headline image
Is This the Best Value Stock to Buy While Markets Are Volatile? ↗
This big pharma stock should be even more appealing to investors amid market turbulence. 
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
Want Over $7,000 in Annual Dividends? Invest $25,000 in Each of These 4 Stocks. ↗
Although the U.S. stock market is trading close to an all-time high, its dividend yield is approaching a 20-year low, and that's creating a challenge for income-oriented investors. 
Via The Motley Fool
News headline image
What's going on in today's session: S&P500 most active stocks ↗
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
News headline image
Novo Nordisk Shares Plunge as Alzheimer's Drug Trial Fails to Meet Primary Endpoint
Copenhagen, Denmark – November 24, 2025 – Novo Nordisk's (CPH: NOVO B) stock experienced a significant and immediate downturn today, plummeting by over 10% in early trading, following the announcement... 
Via MarketMinute
News headline image
Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)
From Arvinas Inc.
Via GlobeNewswire
News headline image
2 High-Yield Dividend ETFs to Buy to Generate Passive Income ↗
The Schwab U.S. Dividend Equity ETF and Alerian MLP ETF are two nice high-yield ETF options. 
Via The Motley Fool
Topics ETFs Retirement Stocks
News headline image
2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon ↗
For those with decades left in their investing journey, these top healthcare stocks could be worthy portfolio contenders. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. 
Via StockStory
Topics Economy
News headline image
Why Are Shares of Pfizer Up Today? ↗
Pfizer rises after a study found that the company's new mRNA flu vaccine outperforms traditional shots against predominant strains. 
Via Benzinga
News headline image
Which S&P500 stocks are the most active on Friday? ↗
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for... 
Via Chartmill
News headline image
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
From Pfizer Inc.
Via Business Wire
News headline image
Texas AG Sues Sanofi And Bristol-Myers Over Alleged Failures To Warn About Risks Associated With Blood Thinner Drug ↗
Texas sues Sanofi and Bristol-Myers Squibb over alleged Plavix failures, as Paxton also finalizes a $41.5 million settlement with Pfizer and Tris over quality issues in children's medication. 
Via Benzinga
Topics Lawsuit
News headline image
This 7%-Yielding Dividend Stock Is About to Enter an Exciting New Phase ↗
The drugmaker may not continue to lag the market for much longer. 
Via The Motley Fool
News headline image
Goldman Sachs Just Delivered Bad News for U.S. Investors ... Sort Of. Here's What You Need to Know. ↗
The investment bank's analysts simply recognize how much has changed in just the past few years, and what that means for the near future. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
AI Unleashes a Healthcare Revolution: Smarter Care, Empowered Providers, Healthier Nation
Artificial intelligence is rapidly transforming America's healthcare system, offering immediate and profound benefits across the entire spectrum of care, from individual patients to providers and... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Exact Sciences Stock Pops on $21 Billion Deal. Is It Too Late to Buy EXAS Here?
Exact Sciences stock rallies as Abbott announces a $21 billion deal to acquire to the molecular diagnostics firm. Here’s why EXAS shares are unlikely to push any higher in 2026. 
Via Barchart.com
News headline image
Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session. ↗
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
News headline image
Is Pfizer's 6.9%-Yielding Dividend Still Safe? ↗
The company's earnings fell by 21% last quarter. 
Via The Motley Fool
News headline image
Cincinnati Financial Stock Outlook: Is Wall Street Bullish or Bearish?
Although Cincinnati Financial has lagged behind the SPX over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects. 
Via Barchart.com
News headline image
Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For
From BioMedWire
Via GlobeNewswire
News headline image
Zoetis (ZTS): Buy, Sell, or Hold Post Q3 Earnings?
Zoetis’s stock price has taken a beating over the past six months, shedding 28.6% of its value and falling to a new 52-week low of $116.88 per share. This was partly due to its softer quarterly results... 
Via StockStory
News headline image
Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too?
Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech. Have the good days finally come to an end? 
Via Barchart.com
News headline image
Gold Steadfast Amidst Stock Market Jitters and Fed Rate Cut Speculation
As November 2025 unfolds, the financial markets find themselves in a delicate balance, with gold demonstrating remarkable resilience and even significant appreciation, while global stock markets... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Federal Shutdown Leaves October Jobs Report Unreleased, Markets "Flying Blind"
Washington D.C. – November 19, 2025 – The U.S. Labor Department announced today that it would not release a full jobs report for October due to a prolonged federal government shutdown that recently... 
Via MarketMinute
Topics Credit Cards Economy Government
News headline image
HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? ↗
Via MarketBeat
News headline image
Agios Pharmaceuticals Plunges Over 50% as Sickle Cell Drug Delivers Mixed Phase 3 Results
Boston, MA – November 19, 2025 – Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) experienced a dramatic and immediate market backlash, with its stock plummeting over 51.00% following the announcement of... 
Via MarketMinute
News headline image
Nuvation Bio (NUVB) Soars on IBTROZI's Blockbuster Launch and Stellar Q3 2025 Performance
Boston, MA – November 19, 2025 – Nuvation Bio Inc. (NASDAQ: NUVB) has captured the financial spotlight, witnessing a remarkable 47.71% surge in its stock price following a stellar third-quarter 2025... 
Via MarketMinute
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.